Form 8-K - Current report:
SEC Accession No. 0001193125-24-213225
Filing Date
2024-09-04
Accepted
2024-09-04 17:38:58
Documents
13
Period of Report
2024-08-28
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d886159d8k.htm   iXBRL 8-K 26320
  Complete submission text file 0001193125-24-213225.txt   149276

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA bolt-20240828.xsd EX-101.SCH 2838
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE bolt-20240828_lab.xml EX-101.LAB 17978
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bolt-20240828_pre.xml EX-101.PRE 11250
15 EXTRACTED XBRL INSTANCE DOCUMENT d886159d8k_htm.xml XML 3640
Mailing Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-665-9295
Bolt Biotherapeutics, Inc. (Filer) CIK: 0001641281 (see all company filings)

EIN.: 472804636 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39988 | Film No.: 241278486
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)